VK-2809 Uses, Dosage, Side Effects and more
VK-2809 is under investigation in clinical trial NCT02927184 (Safety and Tolerability of VK2809 in Patients With Primary Hypercholesterolemia and Non-Alcoholic Fatty Liver Disease).
Trade Name | VK-2809 |
Generic | VK-2809 |
Type | |
Formula | C28H32ClO5P |
Weight | Average: 514.98 Monoisotopic: 514.1675888 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |